Select Page

8936 Blakeney Professional Drive 
Charlotte, NC 28277

Clinical Trials and Research

Dermatology Specialists of Charlotte offers Clinical Trials and Research in Dermatology

We are currently looking for research participants for:

  • Acne (nutritional supplement)
  • Alopecia Areata
  • Atopic Dermatitis
  • Hidradenitis Suppurativa
  • Psoriatic Arthritis

If interested, call the office (704-943-3714) and choose option 6 to speak with our research coordinator. Or email research@dscmd.com for more information.

Dermatology Specialists of Charlotte in partnership with DJL Research Network currently enrolling in the following trials:

Alopecia Areata

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata

  • Participants must be at least 18 years and ≤60 years for males (≤70 years of age for females)
  • Current AA episode of more than 6 months’ duration and hair loss encompassing at least half of the scalp

Atopic Dermatitis

A Randomized, Double-Blind, Placebo-Controlled Efficacy Study of The Neurokinin-1 Receptor Antagonist VLY-686 in Patients With Atopic Dermatitis

Inclusion Criteria:

  • Male and non-pregnant, non-lactating female patients aged 18 – 70 years (inclusive);
  • Diagnosed with atopic dermatitis;
  • Suffering from chronic pruritus;
  • Body Mass Index (BMI) of ≥18 and ≤40 kg/m2

Exclusion Criteria:

  • Chronic pruritus due to condition other than atopic dermatitis (AD);
  • A positive test for drugs of abuse at the screening or evaluation visits;
  • Exposure to any investigational medication in the past 60 days

Hidradenitis Suppurativa

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 2 Study to Evaluate the Safety and Efficacy of Avacopan in Subjects with Moderate to Severe Hidradenitis Suppurativa

Inclusion Criteria:

  • Aged at least 18 years of age;
  • Clinical diagnosis of HS (Hurley Stage II or III)

Acne Vulgaris

A Randomized, Double Blind, Phase 2, Comparative 16-Week Study of ACCUMAX SUBLINGUAL (Diindolylmethane, DIM + Vitamin A) and Quercetin vs Placebo in Participants with Moderate to Severe Acne Vulgaris

Inclusion Criteria:

  • 18-45 years
  • Moderate-severe acne vulgaris presenting on the face or on the face and the upper trunk and chest

For more information, visit clinicaltrials.gov

If interested in participating in a clinical trial at DSC, email us at research@dscmd.com